COX‐2 in lung cancer: Mechanisms, development, and targeted therapies

MLA

Xueqi Liu, et al. “COX‐2 in Lung Cancer: Mechanisms, Development, and Targeted Therapies.” Chronic Diseases and Translational Medicine, vol. 10, no. 4, Dec. 2024, pp. 281–92. EBSCOhost, https://doi.org/10.1002/cdt3.120.

APA

Xueqi Liu, Junli Zhang, Wenwu Sun, Jianping Cao, & Zhuang Ma. (2024). COX‐2 in lung cancer: Mechanisms, development, and targeted therapies. Chronic Diseases and Translational Medicine, 10(4), 281–292. https://doi.org/10.1002/cdt3.120

Chicago

Xueqi Liu, Junli Zhang, Wenwu Sun, Jianping Cao, and Zhuang Ma. 2024. “COX‐2 in Lung Cancer: Mechanisms, Development, and Targeted Therapies.” Chronic Diseases and Translational Medicine 10 (4): 281–92. doi:10.1002/cdt3.120.